Patent 7902222 was granted and assigned to Abbott on March, 2011 by the United States Patent and Trademark Office.
The invention relates to biaryl substituted azabicyclic alkane derivatives, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.